রাজডক - Rajdoc
Banolata-2023-03-09.gif
Banolata-2024-03-09.gif

ডাঃ এর সিরিয়াল দিন

Iprasol (100mcg+20mcg)/puff

Inhaler
Salbutamol + Ipratropium Bromide
Beximco Pharmaceuticals Ltd

Other Strength:

Alternative:
- Salpium (100mcg+20mcg)/puff
- Sulprex HFA Inhaler (100mcg+20mcg)/puff



Iprasol
Iprasol is a preparation of Salbutamol & Ipratropium bromide.Salbutamol is a beta2-adrenergic agent which acts on airway smooth muscle resulting in relaxation. Ipratropium Bromide is a anticholinergic agent that works as a bronchodilator that dilates the bronchi in the lungs. Iprasol provides the simultaneous release of ipratropium bromide and salbutamol allowing the synergistic efficacy on the muscarinic and beta2-adrenergic receptors in the airways to cause bronchodilation which is superior to that provided by each single agent and with no potentiation of adverse events.


Offers definite relief to the patients in asthma & COPD
Ensures treatment adherence & patients? compliance
An effective & safer alternative to nebulizer both in home & emergency setting

( Ipratropium Bromide 0.5 mg and Salbutamol 2.5 mg/ml Respirator Solution )

This Inhalation Solution is a combination of the anticholinergic bronchodilator, ipratropium bromide, and the ß2-adrenergic bronchodilator, salbutamol sulfate. Ipratropium bromide is a quaternary ammonium derivative of atropine and is an anticholinergic drug which has bronchodilator properties. On inhalation, the onset of action is noted within 5 to 15 minutes, with a peak response between 1 and 2 hours, lasting about 2 additional hours, with subsequent decline from the peak. Bronchodilation is still evident 8 hours after inhalation. Salbutamol produces bronchodilation through stimulation of ß2-adrenergic receptors in bronchial smooth muscle, thereby causing relaxation of muscle fibres. This action is manifested by an increase in pulmonary function as demonstrated by spirometric measurements. A measurable decrease in airway resistance is typically observed 5 to 15 minutes after inhalation of salbutamol. The maximum improvement in pulmonary function usually occurs after 60 to 90 minutes, and significant bronchodilator activity has been observed to persist from 3 to 6 hours.

এই পাতাটি ২৩৫ বার দেখা হয়েছে


যোগাযোগ
প্যারামেডিকেল রোড
লক্ষ্মীপুর, রাজশাহী
Email: info@rajdoc.com
Phone: +8801753226626